The structure of suramin on page 844 is incorrect; the correct structure is shown below:
The following paragraph and associated reference were mistakenly omitted from the discussion of the role of sirtuins in cancer on page 850: "In a recent effort to identify activators of p53 in a mammalian cell-based screen, a reporter construct was placed under the regulation of a p53 target promoter, and active compounds that increased reporter activity were selected from the library screen. This strategy led to the identification of a series of compounds called tenovins 1 ."
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